Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

BD Corp. taps execs as investors

This article was originally published in The Gray Sheet

Executive Summary

President and CEO Edward Ludwig is required to own company stock in the company representing five times his annual salary, BD notes in a proxy statement for its Feb. 13 annual shareholders' meeting. Ludwig's base salary was $730,000 in 2001, placing his stock ownership requirement in the $3.8 mil. range, or over 100,000 shares at recent trading levels. "Stock options, including vested options, are not included in determining whether an individual has met his or her ownership guidelines," the proxy says, and the company "does not, and has not, provided any loans to management for the purpose of assisting them in satisfying these ownership guidelines"...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT016031

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel